Anthony Maddaluna - 30 Sep 2022 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Director
Signature
/s/ Anthony Maddaluna
Issuer symbol
INDP
Transactions as of
30 Sep 2022
Transactions value $
$0
Form type
4
Date filed
03 Oct 2022, 16:30
Previous filing
06 Aug 2021
Next filing
30 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (right to buy) Award $0 +13.8K $0.00 13.8K 30 Sep 2022 Common Stock 13.8K $2.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable on September 30, 2023.